These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 28351732)

  • 1. Prevalence of factor H Binding Protein sub-variants among Neisseria meningitidis in China.
    Shi F; Zhang A; Zhu B; Gao Y; Xu L; Li Y; Yin Z; Li J; Xie N; Shao Z
    Vaccine; 2017 Apr; 35(18):2343-2350. PubMed ID: 28351732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets.
    Law DK; Lefebvre B; Gilca R; Deng S; Zhou J; De Wals P; Tsang RS
    BMC Microbiol; 2015 Jul; 15():143. PubMed ID: 26204985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neisseria meningitidis serogroup B carriage by adolescents and young adults living in Milan, Italy: Prevalence of strains potentially covered by the presently available meningococcal B vaccines.
    Terranova L; Principi N; Bianchini S; Di Pietro G; Umbrello G; Madini B; Esposito S
    Hum Vaccin Immunother; 2018 May; 14(5):1070-1074. PubMed ID: 29584565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad vaccine protection against Neisseria meningitidis using factor H binding protein.
    Findlow J; Bayliss CD; Beernink PT; Borrow R; Liberator P; Balmer P
    Vaccine; 2020 Nov; 38(49):7716-7727. PubMed ID: 32878710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates.
    Marsh JW; Shutt KA; Pajon R; Tulenko MM; Liu S; Hollick RA; Kiehlbauch JA; Clark TA; Stephens DS; Arnold KE; Myers RA; Mayer LW; Harrison LH
    Vaccine; 2011 Aug; 29(35):6049-58. PubMed ID: 21704667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation of the factor H-binding protein of Neisseria meningitidis.
    Brehony C; Wilson DJ; Maiden MCJ
    Microbiology (Reading); 2009 Dec; 155(Pt 12):4155-4169. PubMed ID: 19729409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics Analysis of Global Diversity in Meningococcal Vaccine Antigens over the Past 10 Years: Vaccine Efficacy Prognosis.
    Savitskaya VY; Dolinnaya NG; Strekalovskikh VV; Peskovatskova ES; Snyga VG; Trefilov VS; Monakhova MV; Kubareva EA
    Med Sci (Basel); 2023 Dec; 11(4):. PubMed ID: 38132917
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine.
    Green LR; Lucidarme J; Dave N; Chan H; Clark S; Borrow R; Bayliss CD
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29950334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive Genetic Diversity and Epidemiological Patterns of Factor H-Binding Protein Variants among
    Tan Z; Xu J; Che J; Xu L; Yan D; Zhang M; Shao Z
    Microorganisms; 2024 Feb; 12(3):. PubMed ID: 38543533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PorA variable antigenic regions VR1, VR2, and VR3 of Neisseria meningitidis serogroups B and C isolated in Brazil from 1999 to 2004.
    de Filippis I; de Andrade CF; Silva L; Prevots DR; Vicente AC
    Infect Immun; 2007 Jul; 75(7):3683-5. PubMed ID: 17502397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003.
    Zhou J; Lefebvre B; Deng S; Gilca R; Deceuninck G; Law DK; De Wals P; Tsang RS
    J Clin Microbiol; 2012 May; 50(5):1545-51. PubMed ID: 22337990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targets in meningococci: efficient routine characterization and optimal outbreak investigation in conjunction with routine surveillance of the meningococcal group B vaccine candidate, fHBP.
    Lucidarme J; Newbold LS; Findlow J; Gilchrist S; Gray SJ; Carr AD; Hewitt J; Kaczmarski EB; Borrow R
    Clin Vaccine Immunol; 2011 Feb; 18(2):194-202. PubMed ID: 21123522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes.
    Konar M; Pajon R; Beernink PT
    Proc Natl Acad Sci U S A; 2015 Dec; 112(48):14823-8. PubMed ID: 26627237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Characterization of Urethritis-Associated Neisseria meningitidis Shows that a Wide Range of N. meningitidis Strains Can Cause Urethritis.
    Ma KC; Unemo M; Jeverica S; Kirkcaldy RD; Takahashi H; Ohnishi M; Grad YH
    J Clin Microbiol; 2017 Dec; 55(12):3374-3383. PubMed ID: 28904187
    [No Abstract]   [Full Text] [Related]  

  • 15. Meningococcal factor H-binding protein: implications for disease susceptibility, virulence, and vaccines.
    Yee WX; Barnes G; Lavender H; Tang CM
    Trends Microbiol; 2023 Aug; 31(8):805-815. PubMed ID: 36941192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthy Vaccinee Bias and MenB-FHbp Vaccine Effectiveness Against Gonorrhea.
    Abara WE; Bernstein KT; Lewis FMT; Pathela P; Islam A; Eberhart M; Cheng I; Ternier A; Sanderson Slutsker J; Madera R; Kirkcaldy R
    Sex Transm Dis; 2023 Jun; 50(6):e8-e10. PubMed ID: 36863060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ion torrent personal genome machine sequencing for genomic typing of Neisseria meningitidis for rapid determination of multiple layers of typing information.
    Vogel U; Szczepanowski R; Claus H; Jünemann S; Prior K; Harmsen D
    J Clin Microbiol; 2012 Jun; 50(6):1889-94. PubMed ID: 22461678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of
    Peters S; Mohort K; Claus H; Stigloher C; Schubert-Unkmeir A
    Front Cell Infect Microbiol; 2024; 14():1389527. PubMed ID: 38756230
    [No Abstract]   [Full Text] [Related]  

  • 19. Transcriptional profiling of serogroup B Neisseria meningitidis growing in human blood: an approach to vaccine antigen discovery.
    Hedman ÅK; Li MS; Langford PR; Kroll JS
    PLoS One; 2012; 7(6):e39718. PubMed ID: 22745818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence diversity of Neisseria meningitidis 16S rRNA genes and use of 16S rRNA gene sequencing as a molecular subtyping tool.
    Sacchi CT; Whitney AM; Reeves MW; Mayer LW; Popovic T
    J Clin Microbiol; 2002 Dec; 40(12):4520-7. PubMed ID: 12454145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.